retinitis pigmentosa

Optogenetics Restores Some Vision in Advanced Retinitis Pigmentosa Patient

Wednesday, September 8 2021 | 10 h 43 min | Vision Science

Scientists have reported that a patient achieved partial recovery of sight in a Phase I/II optogenetics therapy clinical trial The study sponsored...

Organic Retinal Prosthesis Restores Vision in Rats

Thursday, March 16 2017 | 00 h 00 min | Vision Science

Scientists at the Italian Institute of Technology have developed a prosthesis that can be implanted into the eye to serve as a substitute for the...

Clinical Trial Demonstrates Safety, Benefits of Bionic Eye

Monday, June 29 2015 | 00 h 00 min | Vision Science

The results of the 3-year clinical trial of the Argus II retinal prosthesis system, a “bionic eye” developed by Second Sight Medical Products to...

CooperVision Appoints Alex Wilkes as President, Americas

CooperVision has named Alex Wilkes as President, Americas, effective June 14. Wilkes brings more than a decade of experience in the eye care industry, having most recently served as Senior Vice President and General Manager of Pearle Vision at Luxottica.

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

A Successful First Half Year for ZEISS

The positive trend continues at the ZEISS Group, which had a positive end to the first six months of fiscal year 2021/22 (ended 31 March 2022) that was significantly higher than the very good result seen in the previous year.

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

CooperVision Appoints Alex Wilkes as President, Americas

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

CooperVision Appoints Alex Wilkes as President, Americas

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

CooperVision Appoints Alex Wilkes as President, Americas

Learn More

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

LUMIFY® is Canada's First and Only Over-the-Counter Eye Drop with Low-Dose Brimonidine for the Relief of Eye Redness

Lanvin Unveils New Mother and Child Sunglasses

These feminine sunglasses are designed in an oversized rectangular silhouette, crafted in lightweight acetate.

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

After the successful 2021 reunion, the upcoming edition heralds a return to normalcy and the much-awaited SILMO Paris.

Tag: retinitis pigmentosa

Optogenetics Restores Some Vision in Advanced Retinitis Pigmentosa Patient

Organic Retinal Prosthesis Restores Vision in Rats

Clinical Trial Demonstrates Safety, Benefits of Bionic Eye

Featured Posts

CooperVision Appoints Alex Wilkes as President, Americas

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Lanvin Unveils New Mother and Child Sunglasses

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

CooperVision Appoints Alex Wilkes as President, Americas

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Lanvin Unveils New Mother and Child Sunglasses

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

CooperVision Appoints Alex Wilkes as President, Americas

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Lanvin Unveils New Mother and Child Sunglasses

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy

CooperVision Appoints Alex Wilkes as President, Americas

Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops

Lanvin Unveils New Mother and Child Sunglasses

A Successful First Half Year for ZEISS

SILMO Paris 2022: Return to Normalcy